Špela Pintar

1PUBLICATIONS
4CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 24, 2024
Remission Is Maintained after Switch from Dose-Optimised Intravenous Treatment to Subcutaneous Treatment with Vedolizumab in Inflammatory Bowel Disease.

Špela Pintar, Jurij Hanžel, David Drobne

Pageof 1

Frequent Collaborators

1 joint publications

Jurij Hanžel

1 joint publications

David Drobne

1 joint publications

Nataša Smrekar

1 joint publications

Gregor Novak